Standout Papers

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults 2023 2026 202485
  1. Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults (2023)
    Ann R. Falsey, Kristi L. Williams et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

Global trends in antibiotic consumption during 2016–2023 and future projections through 2030
2024 Standout
The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis
2024 Standout
3 intermediate papers

Works of John Ervin being referenced

Randomized, Double‐Blind, Placebo‐Controlled Trial of Intraarticular Trans ‐ Capsaicin for Pain Associated With Osteoarthritis of the Knee
2019
Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
John Ervin 265 61 129 174 20 657
S. A. Muller 129 67 105 85 29 729
Andrea Restrepo 156 12 73 139 22 619
Jean‐Paul Brion 246 96 44 235 32 705
Donald Rudikoff 128 104 105 104 43 740
Louise Mooney 258 37 47 287 16 724
Markus Mühlemann 197 48 58 82 23 607
Samuel R. Marney 173 234 37 88 20 694
Enrico Iemoli 197 77 121 267 25 849
Manon Paradis 153 35 38 239 32 775
Eulalia Valle-Garay 155 160 79 96 36 787

All Works

Loading papers...

Rankless by CCL
2026